157 related articles for article (PubMed ID: 32313107)
1. Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome.
Tomlinson CG; Sasa G; Aubert G; Martin-Giacalone B; Plon SE; Bryan TM; Bertuch AA; Gramatges MM
Leukemia; 2021 Jan; 35(1):269-273. PubMed ID: 32313107
[No Abstract] [Full Text] [Related]
2. Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple
Lodé L; Ameur A; Coste T; Ménard A; Richebourg S; Gaillard JB; Le Bris Y; Béné MC; Lavabre-Bertrand T; Soussi T
Haematologica; 2018 Jan; 103(1):e13-e16. PubMed ID: 29079597
[No Abstract] [Full Text] [Related]
3. Recurrent mutations in multiple components of the SWI/SNF complex in myelodysplastic syndromes and acute myeloid leukaemia.
Yao H; Huo L; Ping N; Liu H; Li H; Ding Z; Shen H; Xie J; Qiu Q; Ma L; Jiang A; Wang Q; Wu D; Yang X; Song Y; Chen S
Br J Haematol; 2022 Jan; 196(2):441-444. PubMed ID: 34535894
[No Abstract] [Full Text] [Related]
4. RUNX1 mutations in MDS, s-AML, and de novo AML: differences in accompanying genetic alterations and outcome.
Stengel A; Kern W; Meggendorfer M; Haferlach T; Haferlach C
Leuk Lymphoma; 2019 May; 60(5):1334-1336. PubMed ID: 30997874
[No Abstract] [Full Text] [Related]
5. Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia.
McGraw KL; Nguyen J; Komrokji RS; Sallman D; Al Ali NH; Padron E; Lancet JE; Moscinski LC; List AF; Zhang L
Haematologica; 2016 Aug; 101(8):e320-3. PubMed ID: 27081179
[No Abstract] [Full Text] [Related]
6. The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.
Zhang L; McGraw KL; Sallman DA; List AF
Leuk Lymphoma; 2017 Aug; 58(8):1777-1790. PubMed ID: 27967292
[TBL] [Abstract][Full Text] [Related]
7. Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome.
Iacobucci I; Mullighan CG
Curr Opin Hematol; 2021 Mar; 28(2):101-109. PubMed ID: 33427759
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
[TBL] [Abstract][Full Text] [Related]
9. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.
El Ghannam D; Taalab MM; Ghazy HF; Eneen AF
Blood Cells Mol Dis; 2014; 53(1-2):61-6. PubMed ID: 24512939
[TBL] [Abstract][Full Text] [Related]
10. Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia.
Thol F; Scherr M; Kirchner A; Shahswar R; Battmer K; Kade S; Chaturvedi A; Koenecke C; Stadler M; Platzbecker U; Thiede C; Schroeder T; Kobbe G; Bug G; Ottmann O; Hofmann WK; Kröger N; Fiedler W; Schlenk R; Döhner K; Döhner H; Krauter J; Eder M; Ganser A; Heuser M
Haematologica; 2015 Apr; 100(4):e122-4. PubMed ID: 25552704
[No Abstract] [Full Text] [Related]
11. High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia.
Karimi M; Nilsson C; Dimitriou M; Jansson M; Matsson H; Unneberg P; Lehmann S; Kere J; Hellström-Lindberg E
Haematologica; 2015 Jun; 100(6):e223-5. PubMed ID: 25769547
[No Abstract] [Full Text] [Related]
12. Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.
Gonçalves AC; Alves R; Baldeiras I; Cortesão E; Carda JP; Branco CC; Oliveiros B; Loureiro L; Pereira A; Nascimento Costa JM; Sarmento-Ribeiro AB; Mota-Vieira L
Mol Carcinog; 2017 Jan; 56(1):130-148. PubMed ID: 26950655
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
[TBL] [Abstract][Full Text] [Related]
14. Involvement of a member of the histone cluster 1 at 6p21 in NUP98-positive MDS/AML.
Di Giacomo D; Pierini V; La Starza R; Borlenghi E; Pellanera F; Lema Fernandez AG; Bellotti D; Lamorgese C; Rossi G; Mecucci C
Leuk Lymphoma; 2017 Nov; 58(11):2765-2767. PubMed ID: 28482724
[No Abstract] [Full Text] [Related]
15. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Tawana K; Drazer MW; Churpek JE
Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes.
Christopeit M; Bartholdy B
Epigenomics; 2014; 6(4):371-4. PubMed ID: 25333846
[No Abstract] [Full Text] [Related]
17. Cytopenias + mutations - dysplasia = what?
Steensma DP
Blood; 2015 Nov; 126(21):2349-51. PubMed ID: 26585803
[No Abstract] [Full Text] [Related]
18. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Nardi V; Hasserjian RP
Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
[TBL] [Abstract][Full Text] [Related]
19. Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.
Bidet A; Dulucq S; Smol T; Marceau-Renaut A; Morisset S; Coiteux V; Noël-Walter MP; Nicolini FE; Tigaud I; Luquet I; Struski S; Gaillard B; Penther D; Tondeur S; Nadal N; Hermet E; Véronèse L; Réa D; Gervais C; Theisen O; Terré C; Cony-Makhoul P; Lefebvre C; Gaillard JB; Radford I; Vervaeke AL; Barin C; Chapiro E; Nguyen-Khac F; Etienne G; Preudhomme C; Mahon FX; Roche-Lestienne C;
Haematologica; 2019 Jun; 104(6):1150-1155. PubMed ID: 30573507
[TBL] [Abstract][Full Text] [Related]
20. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
